Autoimmune and Inflammatory Myelopathies

Autoimmune and inflammatory myelopathies encompass a group of disorders affecting the spinal cord, characterized by immune system dysfunction leading to inflammation and damage to the spinal cord tissues. These conditions can have various causes and presentations, but they share the common feature of the immune system mistakenly attacking the body's own tissues. One of the well-known autoimmune myelopathies is neuromyelitis optica spectrum disorder (NMOSD), formerly known as Devic's disease, which primarily targets the optic nerves and spinal cord. Another is transverse myelitis, characterized by inflammation across one segment of the spinal cord, leading to weakness, sensory disturbances, and sometimes paralysis below the affected area. Inflammatory myelopathies frequently arise from disorders like multiple sclerosis (MS), wherein the immune system targets the myelin sheath enveloping nerve fibers within the spinal cord and brain, resulting in disruptions in the transmission of signals between the brain and the body. Diagnosis of autoimmune and inflammatory myelopathies typically involves clinical evaluation, imaging studies like MRI, and sometimes cerebrospinal fluid analysis to detect signs of inflammation and immune system activity. Treatment strategies aim to reduce inflammation, suppress immune system activity, and manage symptoms. This may involve corticosteroids, immunosuppressive medications, plasma exchange, and physical therapy to enhance function and mobility. Early diagnosis and intervention are crucial to prevent irreversible damage and improve long-term outcomes for individuals affected by these conditions.